Photo from Memorial Sloan Kettering Radiation Oncology/X
May 26, 2024, 14:40
New study by Eric Rios-Doria et al. on early-stage endometrioid endometrial cancer
Memorial Sloan Kettering Radiation Oncology shared a post on X:
“New in IJGC:
In this cohort of patients with early-stage endometrioid endometrial cancer and isolated tumor cells (ITCs) vs true node-negative disease, those with ITC had a less favorable path and got more adjuvant therapy with similar survival.”
Read further
Source: Memorial Sloan Kettering Radiation Oncology/X